The Sec61 translocon is a therapeutic vulnerability in multiple myeloma.
Domenger A, Choisy C, Baron L, Mayau V, Perthame E, Deriano L, Arnulf B, Bories JC, Dadaglio G, Demangel C.
Domenger A, et al. Among authors: choisy c.
EMBO Mol Med. 2022 Mar 7;14(3):e14740. doi: 10.15252/emmm.202114740. Epub 2022 Jan 11.
EMBO Mol Med. 2022.
PMID: 35014767
Free PMC article.